IRIS
Valenti, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.426
NA - Nord America 1.226
SA - Sud America 457
EU - Europa 359
AF - Africa 50
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.524
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.178
SG - Singapore 814
BR - Brasile 380
CN - Cina 350
VN - Vietnam 118
IT - Italia 76
IE - Irlanda 49
FI - Finlandia 45
AR - Argentina 36
HK - Hong Kong 35
FR - Francia 33
GB - Regno Unito 28
DE - Germania 27
IN - India 27
CA - Canada 21
EC - Ecuador 19
MX - Messico 19
NG - Nigeria 19
BD - Bangladesh 15
RU - Federazione Russa 15
BE - Belgio 14
NL - Olanda 14
SE - Svezia 13
ID - Indonesia 12
JP - Giappone 12
ZA - Sudafrica 12
UA - Ucraina 8
ES - Italia 7
TR - Turchia 7
IQ - Iraq 6
PE - Perù 6
PK - Pakistan 6
TN - Tunisia 6
VE - Venezuela 6
CO - Colombia 5
AU - Australia 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
SK - Slovacchia (Repubblica Slovacca) 4
UZ - Uzbekistan 4
AT - Austria 3
JO - Giordania 3
KE - Kenya 3
PA - Panama 3
PT - Portogallo 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
KW - Kuwait 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
MT - Malta 2
OM - Oman 2
PL - Polonia 2
PY - Paraguay 2
RO - Romania 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CL - Cile 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
IM - Isola di Man 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
NI - Nicaragua 1
NP - Nepal 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TG - Togo 1
UY - Uruguay 1
Totale 3.524
Salva come PNG Salva come JPEG
Città #
Singapore 205
Shanghai 165
Chandler 150
The Dalles 143
Beijing 121
Ashburn 110
Dallas 108
Boardman 80
Dublin 49
Ho Chi Minh City 49
New York 47
Helsinki 45
Hong Kong 35
Los Angeles 35
Milan 31
São Paulo 28
Wilmington 24
San Mateo 23
Lawrence 22
Princeton 22
Benin City 19
Hanoi 19
Santa Clara 17
Paris 15
Brussels 13
Phoenix 13
Brooklyn 12
Seattle 12
Rio de Janeiro 11
Tokyo 11
Amsterdam 9
Ann Arbor 9
London 8
Belo Horizonte 7
Duncan 7
Guayaquil 7
Johannesburg 7
Montreal 7
Munich 7
Curitiba 6
Mogi das Cruzes 6
Orem 6
Salvador 6
Boston 5
Buenos Aires 5
Chennai 5
Chicago 5
Hải Dương 5
Moscow 5
New Delhi 5
Poplar 5
Rome 5
Assago 4
Atlanta 4
Bratislava 4
Brno 4
Can Tho 4
Caraguatatuba 4
Charlotte 4
Council Bluffs 4
Da Nang 4
Esbjerg 4
Feira de Santana 4
Goiânia 4
Haiphong 4
Lima 4
Porto Alegre 4
Quito 4
San Francisco 4
São Bernardo do Campo 4
Tashkent 4
Uberaba 4
Uberlândia 4
Aguascalientes 3
Amman 3
Arapiraca 3
Bergamo 3
Brasília 3
Cabo Frio 3
Calgary 3
Caracas 3
Catania 3
Dhaka 3
Diadema 3
Fairfield 3
Jakarta 3
Kansas City 3
Kyiv 3
Las Vegas 3
Leawood 3
Lấp Vò 3
Mariano Moreno 3
Mexico City 3
Nairobi 3
Naples 3
Ourinhos 3
Panama City 3
Pavia 3
Pelotas 3
Ponta Grossa 3
Totale 1.936
Salva come PNG Salva come JPEG
Nome #
Melanoma in Adolescents and Young Adults (AYAs): An Italian Multi-Centric Retrospective Experience 186
Chronic Hand Eczema (CHE): A Narrative Review 104
Rosacea-like Acute Reaction After Hyaluronic Acid Dermal Filler 100
Brodalumab: a new way to inhibit IL-17 in psoriasis 90
Specific Infiltrate of Hodgkin Lymphoma at Site of Cellulitis Mimicking Secondary Cutaneous Involvement 78
A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever 77
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative study 69
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 67
Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population 65
Apremilast for the treatment of palmo-plantar non-pustular psoriasis: A real-life single-center retrospective study 63
Real-life Effectiveness and Safety of Risankizumab in Moderate-to-severe Plaque Psoriasis: A 40-week Multicentric Retrospective Study 60
Effects of TNF-α inhibition on pre-clinical enthesitis: observational study on 49 psoriatic patients 56
Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab 55
Palmar nodules in a young woman with ulcerative colitis and enteropathic arthritis 54
Reorganization of a Northern Italy dermatology department during the COVID-19 pandemic: is it temporary or the beginning of a new era in dermatology? 53
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks 51
Impact of delay in follow-up due to COVID-19 pandemic on skin cancer progression: a real-life experience from an Italian hub hospital 51
Generalized pustular psoriasis flare in a patient affected by plaque psoriasis after BNT162b2 mRNA COVID-19 vaccine, successfully treated with risankizumab 48
Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab 48
Concomitant Pyoderma Gangrenosum-like and Amicrobial Pustulosis of the Folds: a Case Report 48
A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis—IL PSO (Italian Landscape Psoriasis) 47
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS) 46
Urticarial rash in autoinflammatory syndromes 46
Early predictors of psoriatic arthritis: a delphi based consensus from Italian dermatology centers 42
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52-week multicentre retrospective study-IL PSO (Italian landscape psoriasis) 42
Multiple facial angiofibromas: A manifestation of Frank-ter Haar syndrome? 40
Real-life efficacy of guselkumab in patients with early psoriatic arthritis 40
Noninvasive Assessment and Management of Folliculitis Decalvans by Trichoscopy and Reflectance Confocal Microscopy 40
Real-Life Effectiveness and Safety of Risankizumab in 131 Patients Affected by Moderate-to-Severe Plaque Psoriasis: A 52-Week Retrospective Study 38
Anti-IL-23 and anti-IL-17 drugs for the treatment of non-pustular palmoplantar psoriasis: a real-life retrospective study 36
Upadacitinib 30 mg for the optimal management of moderate-to-severe atopic dermatitis: a 52-week single-center real-world study 36
What Can IBD Specialists Learn from IL-23 Trials in Dermatology? 36
Cutaneous toxicity of CAR T-cell therapy: Case report of a bullous life-threatening reaction 35
Pregnancy outcome of a patient treated with upadacitinib for severe atopic dermatitis 35
Pembrolizumab-induced plaque psoriasis successfully treated with risankizumab in a patient with stage IV cutaneous melanoma 35
Combination intravenous immunoglobulin, oral prednisone, and methotrexate for managing scleromyxedema: case report and literature discussion 34
Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis) 34
Bullous vasculitis associated with Streptococcus pyogenes sepsis 34
Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis 33
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 32
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week Study 32
Risk of peripheral neuropathy in patients with psoriasis and psoriatic arthritis. A prospective cohort study 31
Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options 31
Biologics for the Treatment of Severe Acrodermatitis Continua of Hallopeau: Report of Two Cases Successfully Treated with Ixekizumab and Ustekinumab 31
Efficacy and safety of switching psoriatic patients to bimekizumab: new evidence from clinical trials 31
Intra-Class Switch Among IL-23 Inhibitors for Plaque Psoriasis: Is It Worth It? 30
Effectiveness and safety of upadacitinib for moderate‐to‐severe atopic dermatitis in a real‐world setting: A 52‐week retrospective study 29
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers 29
Arrhythmias and other cardiovascular diseases in young patients (<40 years) with moderate/severe atopic dermatitis: A multicentric study in northern Italy 29
Skin cancers: how to balance the risks and benefits of surgery during COVID-19 pandemic (a Northern Italy single-center experience) 29
Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study 29
An updated safety review of Hidradenitis Suppurativa treatment options 28
Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 28
Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience 28
Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study 28
Connective tissue panniculitis and vitiligo in a patient with stage IV melanoma achieving complete response to dabrafenib and trametinib combination therapy 28
Sub-erythrodermic psoriasis successfully treated with bimekizumab: A case report 28
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study 27
Tralokinumab rapidly improves subjective symptoms and quality of life in patients with moderate-to-severe atopic dermatitis: a real-life 16-week experience 27
Safety of Biologic Therapies in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Viral Hepatitis: A Monocentric Retrospective Study 27
Methotrexate-Induced Mucositis in a Patient With Angioimmunoblastic T-cell Lymphoma 27
Apremilast for the treatment of pustular psoriasis induced by neoadjuvant ifosfamide + etoposide chemotherapy for Ewing Sarcoma: a case report 27
Risankizumab for the treatment of genital psoriasis: A 1-year, real-world experience 26
Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021 26
Safety of anti-IL-23 drugs in patients with moderate-to-severe plaque psoriasis and previous tuberculosis infection: a monocentric retrospective study 26
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic Review 26
Long-term management of pediatric psoriasis with ixekizumab: a case report 26
Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg-IL PSO (Italian Landscape Psoriasis) 26
Topical Pharmacological Treatment of Actinic Keratoses: Focus on Tirbanibulin 1% Ointment 25
A severe case of IgA bullous pemphigoid successfully treated with dupilumab 25
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis) 25
Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study 25
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case‐series 24
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience 24
Upadacitinib for the treatment of atopic dermatitis in the elderly: an Italian case series of seven patients 24
Safety of interleukin inhibitors in patients with plaque psoriasis and history of neoplasms: a multicenter retrospective study - IL PSO (Italian landscape psoriasis) 23
Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals 23
Long-Term Sequential Digital Dermoscopy of Low-Risk Patients May Not Improve Early Diagnosis of Melanoma Compared to Periodical Handheld Dermoscopy 23
Effectiveness and safety of anti-IL-23 and anti-IL-17 biological therapies for psoriasis in elderly patients: Real-world experience from two Italian hospitals 23
Safety of Interleukin Inhibitors in Patients with Plaque Psoriasis and Neoplasm: A Retrospective Study from Two Referral Centers 23
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real‐life Italian multicenter observational study of 250 patients 22
The impact of biologic therapy for moderate-to-severe psoriasis on the immune responses to SARS-CoV-2 infection and vaccination 22
Geometric contour variation in clinical target volume of axillary lymph nodes in breast cancer radiotherapy: an AIRO multi-institutional study 22
Effectiveness of ixekizumab for the treatment of moderate‐to‐severe plaque psoriasis with involvement of difficult‐to‐treat areas: A 52‐week multicenter retrospective study 22
Atypical facial pustular folliculitis by Klebsiella pneumoniae: a case report 22
Thin Amelanotic and Hypomelanotic Melanoma: Clinicopathological and Dermoscopic Features 22
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective Study 21
Nonadherence to immune-modifying therapies during the COVID-19 pandemic: the crucial role of doctor-patient communication in avoiding drug discontinuation 21
Potential Role of Leptin in JAK2 Inhibitor-Associated Weight Gain: A Monocentric Retrospective Study 20
Guidelines How to Integrate Surgery and Targeted Therapy with Biologics for the Treatment of Hidradenitis Suppurativa: Delphi Consensus Statements from an Italian Expert Panel 20
Long-term effectiveness and safety of risankizumab in patients with moderate-to-severe psoriasis with and without cardiometabolic comorbidities: a single-center retrospective study 20
Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience 19
Anorectal melanoma: systematic review of the current literature of an aggressive type of melanoma 19
Effectiveness, Tolerability, and Drug Survival of Risankizumab in a Real-World Setting: A Three-Year Retrospective Multicenter Study-IL PSO (ITALIAN LANDSCAPE PSORIASIS) 19
Real-World Effectiveness and Safety of Upadacitinib and Abrocitinib in Moderate-to-Severe Atopic Dermatitis: A 52-Week Retrospective Study 17
New-onset and flares of psoriasis after COVID-19 infection or vaccination successfully treated with biologics: a case series 17
New and Emerging Biologics and Jak Inhibitors for the Treatment of Prurigo Nodularis: A Narrative Review 15
Serum Lipids Alterations in Patients Under Systemic JAK Inhibitors Treatments in Dermatology: Clinical Aspects and Management 14
State of health and inequalities among Italian regions from 2000 to 2021: a systematic analysis based on the Global Burden of Disease Study 2021 8
Totale 3.623
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.943
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202154 0 0 0 0 0 8 6 8 13 7 1 11
2021/2022110 1 0 3 13 2 3 5 10 26 8 32 7
2022/2023359 55 28 25 58 33 27 0 29 55 29 20 0
2023/2024528 16 37 98 28 11 49 59 45 12 22 52 99
2024/20251.163 13 35 14 19 5 105 87 61 161 222 216 225
2025/20261.407 440 242 217 285 183 40 0 0 0 0 0 0
Totale 3.623